Lineage Cell Therapeutics
LCTX
#8743
Rank
A$0.18 B
Marketcap
$0.86
Share price
-1.91%
Change (1 day)
-47.65%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$50.94 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's total liabilities are A$50.94 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lineage Cell Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$57.23 M-24.7%
2022-12-31A$76.01 M-33.92%
2021-12-31A$0.11 B591.36%
2020-12-31A$16.63 M-17.81%
2019-12-31A$20.24 M51.55%
2018-12-31A$13.35 M16.16%
2017-12-31A$11.49 M-31.29%
2016-12-31A$16.73 M-33.06%
2015-12-31A$25 M68.36%
2014-12-31A$14.85 M-14.36%
2013-12-31A$17.34 M229.64%
2012-12-31A$5.26 M23.39%
2011-12-31A$4.26 M12.2%
2010-12-31A$3.79 M42.43%
2009-12-31A$2.66 M-65.77%
2008-12-31A$7.79 M111.38%
2007-12-31A$3.68 M15.52%
2006-12-31A$3.19 M8.34%
2005-12-31A$2.94 M93.7%
2004-12-31A$1.52 M-67.72%
2003-12-31A$4.71 M-0.48%
2002-12-31A$4.73 M18.41%
2001-12-31A$3.99 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$44.97 M-11.71%๐Ÿ‡บ๐Ÿ‡ธ USA